Research led by oncologists Roberto Leon-Ferre, M.D. and Charles Loprinzi, M.D. of Mayo Clinic has found that the drug oxybutynin helps to reduce the frequency and intensity of hot flashes in women who are unable to take hormone replacement therapy, including breast cancer survivors. Study: Drug reduces hot flash frequency, improves quality of life in breast cancer survivors
Aucun commentaire:
Enregistrer un commentaire